AmbioPharm participated in the 3rd China Peptide Industry Conference

The Peptide-Drugs of China Biochemical Pharmaceutical Industry Association held the 3rd China Peptide Industry Conference (and the 2nd General Meeting of Peptide-Drugs of China Biochemical Pharmaceutical Industry Association)on September 20-22 in Shenzhen, China, to promote the development of peptide industry in China and increase the communication within the industry. As one of the sponsors, AmbioPharm participated in the conference.

Spanning the peptide industry’s cutting-edge research, quality standards, production processes, clinical applications and localization, and explored the paths and countermeasures to promote the rise of strategic emerging industries, the conference was comprised of was one main venue and two satellite venues.

At a satellite meeting, Mr. Guoqing Zhang, Vice President of Manufacturing and Process Development of AmbioPharm, presented “Green Peptide Raw Material Manufacturing and Production Practice”.